Omega Therapeutics Inc

NASDAQ:OMGA  
2.72
-0.06 (-2.16%)
Earnings Announcements

Omega Therapeutics Reports Second Quarter 2021 Financial Results

Published: 09/10/2021 11:12 GMT
Omega Therapeutics Inc (OMGA) - Omega Therapeutics Reports Second Quarter 2021 Financial Results and Outlines Key Corporate Objectives.
Omega Therapeutics Inc - Qtrly Loss per Share $3.36.
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0.05 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.